Pfizer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

02.08.24	Is Pfizer Winning Its $43 Billion Bet? (MotleyFool)
01.08.24	Pfizer Just Confirmed It's a Dividend Investor's Dream Stock (MotleyFool)
01.08.24	Pfizer to Buy a GLP-1 Drugmaker? Here's Why You Shouldn't Count on That Happening (MotleyFool)
01.08.24	Pfizer Just Did This for the First Time in 6 Quarters. Time to Buy? (MotleyFool)
30.07.24	Pfizer (PFE) Q2 2024 Earnings Call Transcript (MotleyFool)
30.07.24	Stock Of The Day: Pfizer Pattern Offers Lessons After Better-Than-Expected Q2 Results (Benzinga)
30.07.24	Pfizer Records First Sales Growth In Its Post-Covid Era And It Owes It To Cancer (Benzinga)
30.07.24	Dow Jumps 200 Points; Pfizer Earnings Top Views (Benzinga)
30.07.24	Pfizer Marks First Revenue Growth Since COVID Revenue Peak In 2022, Lifts Annual Guidance (Benzinga)
30.07.24	Pfizer Reports Strong Second-Quarter 2024 Results And Raises 2024 Guidance (Businesswire)
30.07.24	Pfizer Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call (Benzinga)
29.07.24	How To Earn $500 A Month From Pfizer Stock Ahead Of Q2 Earnings (Benzinga)
26.07.24	Freeport-McMoRan, Pfizer, Danaher And An Industrial Stock: CNBC's 'Final Trades' (Benzinga)
25.07.24	What's Going On With Pfizer Stock Thursday? (Benzinga)
25.07.24	European Commission Approves Pfizer’s DURVEQTIX® (fidanacogene elaparvovec), a One-Time Gene Therapy for Adults with Hemophilia B (Businesswire)
25.07.24	Beware, Wegovy -- Pfizer Is Working on a Competitor (MotleyFool)
24.07.24	Sangamo Stock Spikes As Pfizer Partnership Meets Goal In Late-Stage Study (Benzinga)
24.07.24	This Promising Weight Loss Drug Candidate Could Be a Huge Growth Catalyst for Pfizer (MotleyFool)
24.07.24	Pfizer announces positive results from late-stage trial of hemophilia A treatment (MarketWatch)
24.07.24	Pfizer Announces Positive Topline Results From Phase 3 Study of Hemophilia A Gene Therapy Candidate (Businesswire)
24.07.24	GSK, Pfizer and Moderna face RSV vaccine sales slump (Financial Times)
23.07.24	Pfizer And GSK's ViiV Healthcare's Two-Drug HIV Treatment Matches Gilead's Three-Drug Combo In Major Trial (Benzinga)
22.07.24	Better Dark Horse Weight Loss Drug Stock: Pfizer vs. Roche (MotleyFool)
20.07.24	Could Pfizer Become a Top Weight Loss Drug Stock? Don't Count on It. (MotleyFool)
18.07.24	Pfizer Stock Nears Golden Cross, Signals Potential Upside With Strong Oncology Portfolio (Benzinga)
18.07.24	Pfizer, Cisco, Arch Capital And More: CNBC's 'Final Trades' (Benzinga)
17.07.24	Pfizer And Roche Advance On Their Weight Loss Drug Journeys (Benzinga)
12.07.24	With Oral Anti-Obesity Candidate Development, Pfizer Seeks Relevant And Competitive Presence - Goldman Sachs (Benzinga)
12.07.24	Pfizer, L3Harris Technologies And More: CNBC's 'Final Trades' (Benzinga)
11.07.24	Eli Lilly, Novo Nordisk Shares Dip As Pfizer Ramps Up Diabetes Drug Competition (Benzinga)
11.07.24	Why Pfizer Stock Is Moving Higher on Thursday (Benzinga)
11.07.24	Erster Studie abgebrochen: Pfizer gibt Abnehmpille nicht auf - Neuer Versuch mit Danuglipron (N-TV)
11.07.24	Pharmariese: Pfizer treibt Entwicklung von Abnehmpille voran - Aktie steigt deutlich (Handelsblatt)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Lonza Grp	550.80	5.44 %	K V
CieFinRichemont	134.65	0.75 %	K V
UBS Group	28.51	0.74 %	K V
Holcim	89.86	0.72 %	K V
ABB	51.98	0.08 %	K V
Sika	230.70	-0.56 %	K V
Swiss Life Hldg	687.20	-0.66 %	K V
Givaudan	4’008.00	-0.79 %	K V
Roche Hldg G	253.60	-0.90 %	K V
Kuehne+Nagel Int	203.90	-3.32 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Pfizer Inc Cert.Deposito Arg.Repr. 0.5 Shs

Aktien Top/Flop

Pfizer Peer Group Nachrichten

Meistgelesene Nachrichten